*A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray* Multiple Myeloma, a malignant disorder of plasma cells, has long posed significant challenges in treatment due to its complex nature and tendency to relapse. However, recent advances in therapy are ushering in a new era with the emergence of bispecific antibodies, a promising class of drugs that could reshape the landscape of Multiple Myeloma treatment. For More https://www.delveinsight.com/blog/bispecific-antibodies-for-multiple-myeloma-treatment